Cycling Principles: Why You Don't Run Peptides Forever

Almost every experienced user runs peptides in cycles — a block of "on" weeks, then "off" weeks where no peptide is injected. This isn't tradition copied from steroid culture. It's a response to two real biological phenomena: receptor desensitization and feedback suppression.

Get cycling right and you preserve responsiveness, keep your endogenous systems intact, and avoid the gradual "it used to work better" decline.

Why cycling exists

Three mechanisms push toward cycling:

1. Receptor desensitization (tachyphylaxis). Continuous agonist exposure causes receptors to internalize or downregulate. The same dose produces a smaller response over time.
2. Negative feedback. Peptides that mimic hormones (GHRH analogs, GHS) shift the body's own output down to compensate. Long enough "on," and endogenous production may not recover quickly.
3. Diminishing returns. Most adaptive responses — collagen remodeling, tendon repair, body composition changes — plateau. Running past the plateau costs peptide without adding benefit.

Not every peptide needs aggressive cycling. Healing-focused short courses (BPC-157, TB-500 for a specific injury) are by nature self-limiting. Long-term GHS users are the ones who need to watch this most carefully.

General cycle templates

Compound class	Typical "on"	Typical "off"	Why
BPC-157 (healing protocol)	4–8 weeks	2–4 weeks	Degree of injury, then let the tissue integrate
TB-500	4–6 weeks	4+ weeks	Long half-life means the tail continues working during "off"
GHS (Ipamorelin + CJC-1295)	8–12 weeks	4 weeks	Preserve pituitary responsiveness
MK-677 (oral ghrelin)	8–12 weeks	4–8 weeks	Prolactin, cortisol, insulin-resistance risk
PT-141	As-needed, not chronic	N/A	Acute-use compound
GLP-1 (Semaglutide, Tirzepatide)	Open-ended clinical, taper off	N/A for weight mgmt	Medical context, not cycled like anabolics

These are starting points, not scripture. Your own response, goals, and bloodwork matter more.

How to structure an "on" block

• Ramp if needed. GLP-1s always ramp (titration) to minimize GI side effects. BPC-157 usually doesn't need ramping — jump to protocol dose.
• Split doses for short half-life compounds. Ipamorelin at 100–200mcg 2–3x daily hits more pulses than 500mcg once.
• Track something. Body comp, sleep quality, joint pain, whatever matters for your goal. Without tracking you can't tell if week 10 is still working.

How to structure an "off" block

The "off" block is not just "stop injecting." Useful habits during off:

• Sleep and nutrition carry the weight. Endogenous GH, testosterone, and repair signals run on sleep and protein. Don't let them slack during the off.
• Taper if the compound built up. TB-500 and DAC-modified GHS have long tails — you're still "on" for a couple weeks of "off."
• Log how you feel off-cycle. If the dropoff is dramatic, that's information: you may have been over-reliant or suppressed your own output more than you realized.

Common mistakes

• Running indefinitely because it "still works a little." The small remaining effect may not justify suppressed endogenous function and waste of peptide.
• Swapping peptides endlessly to avoid any off time. Receptor families overlap — rotating between GHRP-2 and Ipamorelin doesn't fully reset the ghrelin receptor.
• Stacking fresh compounds during the off block. Defeats the point. The off block is for your own systems to recover.
• Cycling healing peptides mid-injury. If you started BPC-157 for a tendon tear, finish the repair window before cycling off.
• Copying someone else's 8-on / 4-off schedule without tracking. Your response curve is your own. 6-on / 2-off might fit you better.

Where to go next

• What happens physiologically during the off block: post-cycle considerations.
• Half-life data to plan taper windows: Pepperpedia.
• Dose math across a full cycle: Peppercalc.
• Cycle planning threads: Protocol Discussions forum.